Invention Grant
US08828430B2 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
有权
3' - [（2Z） - [1-（3,4-二甲基苯基）-1,5-二氢-3-甲基-5-氧代-4H-吡唑-4-亚基]肼基] -2'-羟基 - 1,1'-联苯基] -3-羧酸双 - （单乙醇胺）
![3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)](/docs/US/2014-09-09/US08828430B2/abs.jpg.600x600.jpg)
- Patent Title: 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
- Patent Title (中): 3' - [（2Z） - [1-（3,4-二甲基苯基）-1,5-二氢-3-甲基-5-氧代-4H-吡唑-4-亚基]肼基] -2'-羟基 - 1,1'-联苯基] -3-羧酸双 - （单乙醇胺）
-
Application No.: US13272367Application Date: 2011-10-13
-
Publication No.: US08828430B2Publication Date: 2014-09-09
- Inventor: Francis X. Muller , Shivakumar G Kapsi
- Applicant: Francis X. Muller , Shivakumar G Kapsi
- Applicant Address: US DE Wilmington
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US DE Wilmington
- Agent Wayne J. Dustman; Edward R. Gimmi
- Main IPC: A61K9/19
- IPC: A61K9/19 ; A61K31/4152 ; A61K47/34 ; A61K47/26
![3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)](/abs-image/US/2014/09/09/US08828430B2/abs.jpg.150x150.jpg)
Abstract:
Disclosed are novel pharmaceutical compositions containing 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis (monoethanolamine) (eltrombopag olamine) and processes for preparing the same.
Public/Granted literature
Information query
